[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Abstract Text:

J Hanzlik,A Wojnicz,I Wola?ski,J Grzywnowicz,

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Publishing Authors By Initials

J Hanzlik,A Wojnicz,I Wola?ski,J Grzywnowicz,

For similar bacterial infections and mycoses: infection: urinary tract infections research abstracts see: bacterial infections and mycoses: infection: urinary tract infections research

PUBMED ID PMID:

MEDLINE DATE:

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Annales Universitatis Mariae Curie-Sk?odowska. Sec

VOLUME: 41

Page Numbers: 31-40

Journal Abbreviation:

ISSN: 0066-2240

DAY: 21

MONTH: 01

YEAR: 1986

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Information

Number of References:

LANGUAGE: pol

NlmUniqueID: 414101

[Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Keywords Mesh Terms:

KEYWORDS: Urinary Tract Infections

MESH TERMS: drug therapy

Chemical & Substance for Abstract: [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"] Information

Substance Name: rifamycin SV

Registry Number: 6998-60-3

Grant and Affiliation Information for [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]

AFFILIATION:

Country: POLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann Univ Mariae Curie Sklodows

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa" Related Publications

• [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]